| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012786017 |
| P356 | DOI | 10.1038/334530A0 |
| P698 | PubMed publication ID | 2841610 |
| P50 | author | Sergio Abrignani | Q35703439 |
| P2093 | author name string | Berman P | |
| Roosnek E | |||
| Lanzavecchia A | |||
| Gregory T | |||
| P2860 | cites work | Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor | Q28646793 |
| T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV | Q28646817 | ||
| Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors | Q36349536 | ||
| Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. | Q41885910 | ||
| Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein | Q44509170 | ||
| Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus | Q45848179 | ||
| Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? | Q55244743 | ||
| Antigen-specific interaction between T and B cells | Q59063745 | ||
| Activated human T cells can present denatured antigen | Q68811143 | ||
| Epitopes of the CD4 antigen and HIV infection | Q68977389 | ||
| Essential requirement for major histocompatibility complex recognition in T-cell tolerance induction | Q72726082 | ||
| Antigen specific suppression of T-cell responses - the veto concept | Q85702062 | ||
| P433 | issue | 6182 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | 530-532 | |
| P577 | publication date | 1988-08-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | T cells can present antigens such as HIV gp120 targeted to their own surface molecules | |
| P478 | volume | 334 |
| Q36577387 | A circulating reservoir of pathogenic-like CD4+ T cells shares a genetic and phenotypic signature with the inflamed synovial micro-environment |
| Q40879624 | A comparative review of human and equine leucocyte differentiation antigens |
| Q41917408 | A sub-population of circulating porcine gammadelta T cells can act as professional antigen presenting cells |
| Q51984292 | Activated mouse T cells downregulate, process and present their surface TCR to cognate anti-idiotypic CD4+ T cells. |
| Q72238533 | Activated rat T cells synthesize and express functional major histocompatibility class II antigens |
| Q24600786 | Activation of the HLA-DRA gene in primary human T lymphocytes: novel usage of TATA and the X and Y promoter elements |
| Q37869632 | Afferent lymph dendritic cells: a model for antigen capture and presentation in vivo |
| Q89748473 | Allele-specific expression changes dynamically during T cell activation in HLA and other autoimmune loci |
| Q72677270 | Allergen-induced CD23 on CD4+ T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: evidence and regulation |
| Q36797042 | An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag |
| Q41862881 | An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules |
| Q35056428 | Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins |
| Q41065321 | Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells. |
| Q72997029 | Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12 |
| Q41199692 | Antigen presentation in the intestine |
| Q72671314 | Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes |
| Q55241240 | Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones. |
| Q33933624 | Autopresentation of hepatitis B virus envelope antigens by T cells |
| Q67589692 | Binding of T cell receptor to major histocompatibility complex class II-peptide complexes at the single-cell level results in the induction of antigen unresponsiveness (anergy) |
| Q34045174 | CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. |
| Q74582141 | CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals |
| Q41510776 | Carrier-mediated uptake and presentation of a major histocompatibility complex class I-restricted peptide. |
| Q37363448 | Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells |
| Q67899864 | Cellular and humoral antigenic epitopes in HIV and SIV |
| Q42939841 | Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage |
| Q40460133 | Chronic Activation of the Immune System in HIV Infection: Contribution to T Cell Apoptosis and Vβ Selective T Cell Anergy |
| Q33584112 | Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule |
| Q31047483 | Class II MHC self-antigen presentation in human B and T lymphocytes |
| Q35658414 | Clonal patterns in the human immune response to HIV-1 infection |
| Q28289165 | Clonal sketches of the immune response |
| Q28066226 | Close Encounters of Lymphoid Cells and Bacteria |
| Q36232089 | Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines |
| Q47103994 | Conventional CD4+ T cells present bacterial antigens to induce cytotoxic and memory CD8+ T cell responses. |
| Q40918893 | Current concepts in DRA gene regulation |
| Q41722786 | Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus |
| Q46215386 | Designing CD4 immunoadhesins for AIDS therapy |
| Q36194843 | Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients. |
| Q35880498 | Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1 |
| Q43604630 | Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cells |
| Q45409271 | Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen |
| Q38234935 | ERAD and how viruses exploit it. |
| Q36231544 | Early signaling defects in human T cells anergized by T cell presentation of autoantigen |
| Q38749519 | Eimeria tenella-specific chicken T-cell clones reactive to an internal image anti-idiotypic antibody: correlation between biological activities and protective cell-mediated immunity |
| Q44526053 | Enhancement of HIV-specific cytotoxic T lymphocyte responses by zidovudine (AZT) treatment |
| Q41587736 | Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope |
| Q71815145 | Evidence for Th2 cell‐mediated suppression of antibody responses in transgenic, beef insulin‐tolerant mice |
| Q40863577 | Expression of MHC class II in T cells is associated with increased HIV-1 expression |
| Q45869482 | Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection |
| Q64980289 | Failure of correlation between B7 expression and activation of interleukin-2-secreting T cells. |
| Q40347672 | Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men |
| Q46641636 | Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules |
| Q37206430 | Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection |
| Q36370232 | Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells |
| Q36726922 | HIV-l infection diagnosis and management |
| Q42942993 | HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing |
| Q40951387 | Hepatitis B virus immunopathology |
| Q54136124 | Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules. |
| Q24678950 | How can cryptic epitopes trigger autoimmunity? |
| Q26996825 | How viruses use the endoplasmic reticulum for entry, replication, and assembly |
| Q36231793 | Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells |
| Q40855992 | Human autoreactive (Th0) CD4(+) T-cell clones with cytolytic activity recognizing autologous activated T cells as the target |
| Q34582992 | Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains |
| Q40426651 | Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation |
| Q37131908 | Human regulatory T cells and autoimmunity |
| Q33921098 | Identification of a T cell gene expression clock obtained by exploiting a MZ twin design |
| Q41705740 | Immune Response of Mice Infected with Recombinant Vaccinia Viruses Carrying theHIV gagGene |
| Q83694354 | Immunisation with an allogeneic peptide promotes the induction of antigen-specific MHC II(pos) CD4+ rat T cells demonstrating immunostimulatory properties |
| Q36706780 | Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and beta-chemokine production |
| Q38705312 | Immunobiology of the HIV envelope |
| Q67688943 | Immunohistochemical evidence of immune responses to tumor-associated antigens in lymph nodes of colon carcinoma patients |
| Q37851260 | Immunological features of human immunodeficiency virus disease |
| Q37615905 | Immunology of HIV infection |
| Q40487348 | Immunopathologic effect of antigen recognition |
| Q71420861 | Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells |
| Q72715958 | Induction of tolerance in freshly isolated alloreactive CD4+ T cells by activated T cell stimulators |
| Q36724788 | Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells |
| Q41630912 | Inhibitory activity of HIV envelope gp120 dominates over its antigenicity for human T cells |
| Q37944343 | Interactions of HIV gp120 with the CD4 molecule on lymphocytes and in the nervous system |
| Q40822207 | Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells |
| Q41138242 | Involvement of CD80 in the generation of CD4+ cytotoxic T cells. |
| Q77377753 | Lack of fair play in the T cell response |
| Q40861783 | Localization of soluble major histocompatibility class II-peptide complexes on T cell surface |
| Q38665386 | MHC-antigen interaction: what does the T cell receptor see? |
| Q41102979 | Mechanisms of antigen uptake for presentation |
| Q40650026 | Mechanisms of autoimmunity and AIDS: prospects for therapeutic intervention |
| Q33594871 | Mechanisms of immune escape in viral hepatitis |
| Q35532727 | Mechanisms of transplantation immunity |
| Q52477451 | Model-based analysis of CD4+ lymphocyte dynamics in HIV infected individuals. |
| Q52005768 | Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC. |
| Q21131559 | Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps |
| Q37118150 | Multiple roles for CD4+ T cells in anti-tumor immune responses |
| Q52014179 | Mycobacterial antigens induce apoptosis in human purified protein derivative-specific alphabeta T lymphocytes in a concentration-dependent manner. |
| Q33622404 | Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms |
| Q44035282 | Oligopeptide Induction of a Secondary Cytotoxic T-cell Response to Epstein-Barr Virus In Vitro |
| Q41211054 | One cause for the apparent inability of human T cell clones to function as professional superantigen-presenting cells is autoactivation |
| Q67906474 | Palmitic acid conjugation of a protein antigen enhances major histocompatibility complex class II-restricted presentation to T cells |
| Q24634681 | Pathogenesis of human immunodeficiency virus infection |
| Q72564603 | Patterns of major histocompatibility complex class II expression by T cell subsets in different immunological compartments. 2. Altered expression and cell function following activation in vivo |
| Q42808700 | Patterns of major histocompatibility complex class II expression on T cell subsets in different immunological compartments. 1. Expression on resting T cells |
| Q38265506 | Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy. |
| Q40395451 | Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV. |
| Q67519164 | Presentation of superantigen by human T cell clones: a model of T-T cell interaction |
| Q33739043 | Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein |
| Q37610962 | Priming of anti-human immunodeficiency virus (HIV) CD8+ cytotoxic T cells in vivo by carrier-free HIV synthetic peptides |
| Q40808132 | Processing of self-proteins and its impact on shaping the T cell repertoire, autoimmunity and immune regulation |
| Q34255757 | Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes |
| Q56909782 | Professional presentation of antigen by activated human T cells |
| Q33863493 | Quantifying the infectivity of human immunodeficiency virus |
| Q41380908 | Refolding and reconstitution of functionally active complexes of human leukocyte antigen DR2 and myelin basic protein peptide from recombinant alpha and beta polypeptide chains |
| Q40872594 | Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. |
| Q40699495 | Regulatory functions of human CD4(+) T cells recognizing allopeptides in the context of self-HLA class II. |
| Q37128690 | Regulatory interactions among autologous T cell clones. Human bifunctional T cell clones regulate the activity of an autologous T cell clone |
| Q41944000 | Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells |
| Q38206226 | Role of CD4 in normal immunity and HIV infection |
| Q58328348 | Role of Cellular Immunity in Protection against HIV Infection**This article was accepted for publication on 31 October 1996 |
| Q79380868 | Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice |
| Q41588346 | Role of flanking variable sequences in antigenicity of consensus regions of HIV gp120 for recognition by specific human T helper clones |
| Q41602422 | Signal transduction by HLA class II molecules in human T cells: Induction of LFA-1-dependent and independent adhesion |
| Q45132319 | Signal transduction by HLA-DR is mediated by tyrosine kinase(s) and regulated by CD45 in activated T cells |
| Q72524386 | Soluble transferrin mediates targeting of hepatitis B envelope antigen to transferrin receptor and its presentation by activated T cells |
| Q37602533 | Specific interactions between a human CD4+ clone and autologous CD4+ bifunctional immunoregulatory clones |
| Q44859634 | Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies |
| Q24525189 | Structure-function analysis of hepatitis C virus envelope-CD81 binding |
| Q45222694 | Suppression of the immune response by cytotoxic T cells |
| Q41686290 | Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease |
| Q35654574 | T cell memory: a role for MHC class II molecules on T cells? |
| Q40392456 | T cells as antigen-presenting cells |
| Q67675755 | T-T cell interactions are mediated by adhesion molecules |
| Q74074352 | TCR expression and clonality analysis in peripheral blood and lymph nodes of HIV-infected patients |
| Q41532481 | The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions |
| Q36055538 | The auto-regulation model: a unified concept of how HIV regulates its infectivity, pathogenesis and persistence |
| Q36669879 | The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. |
| Q38366893 | The immunopathogenesis of HIV infection |
| Q35066177 | The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response |
| Q41887540 | Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes |
| Q35665886 | Transmembrane domain determinants of CD4 Downregulation by HIV-1 Vpu. |
| Q52112638 | Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. |
| Q41940771 | Use of antibody/peptide constructs to direct antigenic peptides to T cells: Evidence for T cell processing and presentation |
| Q40741570 | Viral-Specific Immunization in AIDS-Related Complex by Photopheresis |
| Q36732665 | gammadelta T cells: novel initiators of adaptive immunity. |
| Q37875768 | γδ T-APCs: a novel tool for immunotherapy? |
Search more.